Hamza YAZGAN, Haşim USLU, Bülent GÜRLER, Mehmet DEMİRDÖVEN, Alparslan TONBUL, Esengül KELEŞ, Bülent BAŞTÜRK, Aydın YILDIRIM, * Arzu GEBEŞÇE1

Retinopathy of prematurity: incidence, risk factors, and evaluation of screening criteria

Background/aim: The goal of this study was to investigate the incidence of retinopathy of prematurity (ROP) and the relationship between risk factors and disease in premature newborns in our neonatal intensive care unit. Materials and methods: A total of 219 premature subjects were retrospectively evaluated for retinopathy. Demographic information, clinical data, and risk factors were reviewed. Results: The gestational ages of the infants included in the study ranged between 25 and 36 weeks, and the birth weights ranged between 670 and 4460 g. In this study, the incidence of ROP was 20.1% (44) in preterm infants: 16 had stage 1 (36.4%), 15 had stage 2 (34.1%), 11 had stage 3 (25%), 1 had stage 4 (2.3%), 1 had stage 5 (2.3%), and 6 had plus (+) disease (7.2%). The risk factors associated with the development of ROP included low birth weight, ventilation treatment, bronchopulmonary dysplasia, and maternal preeclampsia. The risk factors were analyzed with logistic regression analysis. The odds ratios were 5.952 (95% confidence interval [CI]: 2.030 17.447), 20.070 (95% CI: 4.213 95.600), 5.879 (1.916 18.037), and 3.200 (95% CI: 1.002 11.535), respectively. Conclusion: In this study, birth weight, ventilation treatment, bronchopulmonary dysplasia, and maternal preeclampsia were the most important risk factors for the development of ROP.

PDF

___

1. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol 1942; 25: 203204.
2. Hesse L, Eberl W, Schlaud M. Poets CF. Blood transfusion iron load and retinopathy of prematurity. Eur J Pediatr 1997; 156: 465470.
3. Smolkin T, Steinberg M, Sujov P, Mezer E, Tamir A, Makhoul IR. Late postnatal systemic steroids predispose to retinopathy of prematurity in very low birth weight infants: a comparative study. Acta Paediatr 2008; 97: 322326.
4. Hellstrom A, Peruzzi C, Ju M, Engtröm E, Hard A, Liu J, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjödell L et al. Low IGF-1 supresses endothelial cells: direct correlation with clinical retinopathy of prematurity. P Natl Acad Sci USA 2001; 98: 58045808.
5. Smith LE. Pathogenesis of retinopathy of prematurity. Gowth Horm IGF Res 2004; 14: 140144.
6. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007; 10: 133140.
7. Basmak H, Shin A, Erol N, Gursoy HH. Retinopathy of prematurity: screening guidelines need to be reevaluated for developing countries. Eur J Ophthalmol 2010; 20: 752755.
8. Sarikabadayi YU, Aydemir O, Ozen ZT, Aydemir C, Tok L, Oguz SS, Erdeve O, Uras N, Dilmen U. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: frequency and risk factors. Ophthal Epidemiol 2011; 18: 269274.
9. Ugurbas SC, Gulcan H, Canan H, Ankarali H, Torer B, Akova YA. Comparison of UK and US screening criteria for detection of retinopathy of prematurity in a developing nation. J AAPOS 2010; 14: 506510.
10. Akman I, Dmirel U, Yenice O, Ilerisoy H, Kozakoglu H, Ozek E. Screening criteria for retinopathy of prematurity in developing countries. Eur J Ophthalmol 2010; 14: 506511.
11. Binkhathlan AA, Almahmoud LA, Saleh MJ, Srungeri S. Retinopathy of prematurity in Saudi Arabia: incidence risk factors and the applicability of current screening criteria. Br J Ophthalmol 2008; 92: 167169.
12. Chen Y, Li X. Characteristics of severe retinopathy of prematurity patients in China: repeat of the first epidemic? Br J Ophthalmol 2006; 90: 268271.
13. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low weight infants in Singapore. Ann Acad Med Singapore 2005; 34: 169178.
14. Giannantonio C, Papacci P, Cota F, Vento G, Tesfagabir MG, Purcaro V, Lepore D, Molle F, Baldascino A, Romagnoli C. Analysis of risk factors for progression to treatment requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? J Matern Fetal Neonatal Med 2012; 25: 471477.
15. Fortes Fillo JB, Eckert GU, Valiatti FB, Dos Santos PG, Costa MC, Procianoy RS. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP). Grafes Arch Clin Exp Ophthalmol 2010; 248: 893900.
16. Holmström G, Broberger U, Thomassen P. Neonatal risk factors for retinopathy of prematuritya population-based study. Acta Ophthalmol Scand 1998; 76: 204207.
17. Giapros V, Drougia A, Asproudis I, Theocharis P, Andronikou S. Low gestational age and chronic lung disease are synergistic risk factors for retinopathy of prematurity. Early Hum Dev 2011; 87: 653657.
18. Zamorano Jimenez CA, Salgado Valladares M, Velasquez Valassi B. Risk factors associated to retinopathy of prematurity. Gac Med Mex 2012; 148: 1925.
19. Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity: a multivariate statistical analysis. Ophthalmologica 2000; 214: 131135.
20. Akkoyun I, Oto S, Yilmaz G, Yilmaz G, Gurakan B, Tarcan A, Anuk D, Akgun S, Akova YA. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006; 10: 449453.
21. Araz-Ersan B, Kir N, Akarcay K, Aydinoglu-Candan O, Sahinoglu-Keskek N, Demirel A, Akdogan B, Coban A. Epidemiological analysis of retinopathy of prematurity in a referral centre in Turkey. Br J Ophthalmol 2013; 97: 1517.
22. Özkan H, Çetinkaya M, Koksal N, Özmen A, Yıldız M. Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity. J Perinat Med 2011; 39: 523527.
23. Withagen MI, Visser W, Wallenburg HC. Neonatal outcome of temporizing treatment in early onset preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001; 94: 211215.
24. Allegaert K, Coen K, Devlieger H, on behalf of the EpiBel Study group. Threshold retinopathy at threshold of viability. The EpiBel study. Br J Ophthalmol 2004; 88: 239242.
25. Gilbert C. Retinopathy of prematurity: a global perspective of epidemics, population of babies at risk and implications for control. Early Hum Dev 2008; 84: 7782.
26. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A, International NO-ROP group. Characteristics of infants with severe retinopathy in countries with low, moderate and high levels of development: implications for screening programs. Pediatrics 2005; 115: e518e525.
27. American Academy of Pediatrics, American Academy of Ophthalmology Association for Pediatrics Ophthalmology and Strabismus, Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006; 117: 572576.
28. Akçakaya AA, Yaylali SA, Erbil HH, Sadigov F, Aybar A, Aydin N, Akçay G, Acar H, Mesçi C, Yetik H. Screening for retinopathy of prematurity in a tertiary hospital in Istanbul: incidence and risk factors. J Pediatr Ophthalmol Strabismus 2012; 49: 2125.